Kowieski Mark 4
4 · Evoke Pharma Inc · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Kowieski Mark
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-28+13,000→ 13,000 totalExercise: $4.45Exp: 2035-01-27→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]1/36th of the total number of shares subject to the options shall vest on each monthly anniversary of August 7, 2024 (the "Vesting Commencment Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.